-
Loading metrics
Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function
- Matthew J. Strauss,
-
Katherine D. Porter,
Roles Data curation, Formal analysis, Writing – original draft, Writing – review & editing
Affiliation Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC, United States of America
⨯ -
Pamela M. Quizon,
Roles Data curation, Formal analysis
Affiliation Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC, United States of America
⨯ -
Sarah E. Davis,
Roles Data curation, Formal analysis
Affiliation Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC, United States of America
⨯ - Steven Lin,
- Yaxia Yuan,
- Gustavo A. Martinez-Muniz,
- Wei-Lun Sun,
- Chang-Guo Zhan,
-
Jun Zhu
Roles Conceptualization, Formal analysis, Supervision, Writing – review & editing
* E-mail: zhuj@cop.sc.edu
Affiliation Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC, United States of America
⨯
https://orcid.org/0000-0002-4126-6644
Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function
- Matthew J. Strauss,
- Katherine D. Porter,
- Pamela M. Quizon,
- Sarah E. Davis,
- Steven Lin,
- Yaxia Yuan,
- Gustavo A. Martinez-Muniz,
- Wei-Lun Sun,
- Chang-Guo Zhan,
- Jun Zhu
- Published: September 28, 2022
- https://doi.org/10.1371/journal.pone.0275182